Dimensional Fund Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-318,995
| Closed | -$4.83M | – | 3435 |
|
|
2024
Q2 | $4.83M | Sell |
318,995
-79,006
| -20% | -$1.17M | ﹤0.01% | 2498 |
|
|
2024
Q1 | $5.88M | Sell |
398,001
-37,644
| -9% | -$529K | ﹤0.01% | 2505 |
|
|
2023
Q4 | $5.84M | Sell |
435,645
-13,107
| -3% | -$166K | ﹤0.01% | 2514 |
|
|
2023
Q3 | $5.53M | Sell |
448,752
-11,208
| -2% | -$136K | ﹤0.01% | 2499 |
|
|
2023
Q2 | $5.66M | Sell |
459,960
-6,180
| -1% | -$77.3K | ﹤0.01% | 2476 |
|
|
2023
Q1 | $5.73M | Sell |
466,140
-5,233
| -1% | -$61.5K | ﹤0.01% | 2438 |
|
|
2022
Q4 | $5.4K | Sell |
471,373
-928
| -0.2% | -$7.64K | ﹤0.01% | 2422 |
|
|
2022
Q3 | $1.77M | Sell |
472,301
-4,407
| -0.9% | -$20.3K | ﹤0.01% | 2745 |
|
|
2022
Q2 | $2.84M | Sell |
476,708
-5,776
| -1% | -$32.6K | ﹤0.01% | 2636 |
|
|
2022
Q1 | $3.05M | Sell |
482,484
-6,203
| -1% | -$34.9K | ﹤0.01% | 2698 |
|
|
2021
Q4 | $1.91M | Sell |
488,687
-10,681
| -2% | -$46.4K | ﹤0.01% | 2857 |
|
|
2021
Q3 | $2.41M | Sell |
499,368
-18,277
| -4% | -$95.3K | ﹤0.01% | 2802 |
|
|
2021
Q2 | $3.31M | Sell |
517,645
-1,575
| -0.3% | -$10.4K | ﹤0.01% | 2724 |
|
|
2021
Q1 | $3.26M | Sell |
519,220
-31,319
| -6% | -$224K | ﹤0.01% | 2710 |
|
|
2020
Q4 | $3.79M | Sell |
550,539
-16,646
| -3% | -$82.1K | ﹤0.01% | 2619 |
|
|
2020
Q3 | $2.27M | Sell |
567,185
-20,238
| -3% | -$74.4K | ﹤0.01% | 2707 |
|
|
2020
Q2 | $1.96M | Sell |
587,423
-56,463
| -9% | -$193K | ﹤0.01% | 2761 |
|
|
2020
Q1 | $1.38M | Sell |
643,886
-29,244
| -4% | -$85.5K | ﹤0.01% | 2817 |
|
|
2019
Q4 | $2.12M | Buy |
673,130
+6,830
| +1% | +$27.4K | ﹤0.01% | 2842 |
|
|
2019
Q3 | $2.99M | Sell |
666,300
-198,068
| -23% | -$990K | ﹤0.01% | 2761 |
|
|
2019
Q2 | $4.11M | Buy |
864,368
+33,144
| +4% | +$157K | ﹤0.01% | 2703 |
|
|
2019
Q1 | $4.54M | Buy |
831,224
+105,714
| +15% | +$486K | ﹤0.01% | 2676 |
|
|
2018
Q4 | $2.2M | Sell |
725,510
-3,426
| -0.5% | -$11.9K | ﹤0.01% | 2841 |
|
|
2018
Q3 | $3.06M | Buy |
728,936
+133,629
| +22% | +$563K | ﹤0.01% | 2818 |
|
|
2018
Q2 | $2.3M | Buy |
595,307
+125,060
| +27% | +$830K | ﹤0.01% | 2853 |
|
|
2018
Q1 | $2.98M | Buy |
470,247
+214,363
| +84% | +$1.77M | ﹤0.01% | 2776 |
|
|
2017
Q4 | $2.06M | Buy |
255,884
+223,029
| +679% | +$2.08M | ﹤0.01% | 2850 |
|
|
2017
Q3 | $376K | Buy |
+32,855
| New | +$345K | ﹤0.01% | 3141 |
|
Dimensional Fund Advisors's MACK Position: Q3 2024 in Review
Dimensional Fund Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2024, closing a stake of 318,995 shares — an estimated $4.83M sold.
Dimensional Fund Advisors first reported a position in MACK in Q3 2017 and held it in 28 quarters. The position peaked at $5.88M in Q1 2024. 2 funds tracked by Wall St. Rank hold MACK as of Q3 2024.
- Dimensional Fund Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
- Dimensional Fund Advisors sold 318,995 Merrimack Pharmaceuticals, Inc. shares in Q3 2024, an estimated $4.83M.
- Dimensional Fund Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2017 and held it in 28 quarters.
- Dimensional Fund Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $5.88M in Q1 2024.
- 2 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2024.
Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.